Clinical Trial Update: Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients [Phase 4]

View source ↗

Summary

Phase 4 trial updating timing of granulocyte colony-stimulating factor (G-CSF) after chemotherapy in pediatric patients to assess outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Chemotherapy-induced Febrile Neutropenia
• Chemotherapy-induced Neutropenia

Drugs mentioned

• Granulocyte Colony Stimulating Factor (granulocyte colony-stimulating factor (G-CSF))

Snippet

Sponsor: University of Mississippi Medical Center | Conditions: Granulocyte Colony-Stimulating Factor, Chemotherapy-induced Neutropenia | Phase 4 | Status: UNKNOWN